CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
6.22
-0.52 (-7.72%)
Mar 31, 2025, 1:25 PM EDT - Market open
CorMedix Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for CorMedix stock have an average target of 15.14, with a low estimate of 12 and a high estimate of 19. The average target predicts an increase of 143.41% from the current stock price of 6.22.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CorMedix stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $12 | Buy | Reiterates | $12 | +92.93% | Mar 26, 2025 |
| Needham | Needham | Strong Buy Maintains $18 → $12 | Strong Buy | Maintains | $18 → $12 | +92.93% | Mar 26, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +141.16% | Mar 25, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $18 | Buy | Initiates | $18 | +189.39% | Mar 7, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +141.16% | Mar 5, 2025 |
Financial Forecast
Revenue This Year
132.58M
from 43.47M
Increased by 204.98%
Revenue Next Year
162.46M
from 132.58M
Increased by 22.54%
EPS This Year
0.61
from -0.30
EPS Next Year
1.34
from 0.61
Increased by 119.36%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 182.8M | 186.3M | 291.4M | ||
| Avg | 132.6M | 162.5M | 272.3M | ||
| Low | 108.9M | 144.5M | 251.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 320.6% | 40.5% | 79.4% | ||
| Avg | 205.0% | 22.5% | 67.6% | ||
| Low | 150.5% | 9.0% | 54.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.99 | 2.27 | 3.62 | ||
| Avg | 0.61 | 1.34 | 2.56 | ||
| Low | 0.23 | 0.76 | 1.54 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 270.3% | 169.6% | ||
| Avg | - | 119.4% | 90.5% | ||
| Low | - | 24.8% | 14.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.